MD Nexus
History and Physical Examination
Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors (PCSK9 Inhibitors)
Indications
Hyperlipemia
(see enedoxx
Agents
Alirocumab (Praluent)
(see
Alirocumab
, [[Alirocumab]])
Evolocumab (Repatha)
(see
Evolocumab
, [[Evolocumab]])
References
xxx